Jason Hafler

Social media:

Available after registration.

Past investments

  • Proteostasis Therapeutics
  • Science 37
  • ImmuneXcite
  • Aetion
  • NeuroVia
  • Medisafe
  • Lysosomal Therapeutics
  • Sirtris Pharmaceuticals
  • UNUM Therapeutics
  • Immune Design
  • Common Sensing
  • GlycoMimetics
  • NGI
  • Yumanity Therapeutics
  • KAHR medical
  • Kymera Therapeutics
  • Ovid Therapeutics
  • Expansion Therapeutics
  • Imbria Pharmaceuticals
  • Cogent Biosciences
  • Bluebird Bio
  • Abcuro
  • NodThera
  • Fate Therapeutics
  • Minervax
  • Omada Health
  • Selecta Biosciences
  • Edimer Pharmaceuticals
  • Icosavax
  • Navitor Pharmaceuticals
  • DiCE Molecules
  • Escient Pharmaceuticals
  • Evidation Health
  • Curisium
  • Click Therapeutics
  • Q32 Bio
  • Veralox Therapeutics
  • Lumena Pharmaceuticals
  • Lava Therapeutics
  • Inozyme
  • i2o Therapeutics